Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273,598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Organoarsenic Roxarsone Promotes Angiogenesis In Vivo.
Zhang Y, Wang Y, Lu Q, Xin W, Cui W, Zhu J. Zhang Y, et al. Among authors: wang y. Basic Clin Pharmacol Toxicol. 2016 Apr;118(4):259-70. doi: 10.1111/bcpt.12501. Epub 2015 Nov 13. Basic Clin Pharmacol Toxicol. 2016. PMID: 26450128 Free article.
Roxarsone induces angiogenesis via PI3K/Akt signaling.
Wang Y, Yin D, Xu C, Wang K, Zheng L, Zhang Y. Wang Y, et al. Among authors: wang k. Cell Biosci. 2016 Sep 28;6:54. doi: 10.1186/s13578-016-0119-1. eCollection 2016. Cell Biosci. 2016. PMID: 27708768 Free PMC article.
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Jacobs SA, Wang Y, Abraham J, Feng H, Montero AJ, Lipchik C, Finnigan M, Jankowitz RC, Salkeni MA, Maley SK, Puhalla SL, Piette F, Quinn K, Chang K, Nagy RJ, Allegra CJ, Vehec K, Wolmark N, Lucas PC, Srinivasan A, Pogue-Geile KL. Jacobs SA, et al. Among authors: wang y. Breast Cancer Res. 2024 May 24;26(1):83. doi: 10.1186/s13058-024-01833-6. Breast Cancer Res. 2024. PMID: 38790033 No abstract available.
273,598 results
You have reached the last available page of results. Please see the User Guide for more information.